We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Port Erin | LSE:PEBI | London | Ordinary Share | IM00B6QH1J21 | ORD 0.0001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.50 | 4.00 | 5.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPEBI
RNS Number : 7471W
Port Erin Biopharma Investments Ltd
28 April 2016
29 April 2016
Port Erin Biopharma Investments Limited
(the "Company")
Net Asset Value calculation to 31 March 2016
Jim Mellon, Chairman, commented: -
"The Net Asset Value ("NAV") calculation for the Company as at closing on 31 March 2016 was 10.21 pence per share, including un-invested cash of GBP10,713. The portfolio is valued under IFRS at bid price.
Net Assets stand at GBP2.4 million including Investments of GBP2.38 million. This quarter's NAV represents a decrease of 5.37% from the previous valuation of 10.79 pence per share, which included un-invested cash of GBP24,011. No additional management fee is due to Shellbay Investments Limited."
Unaudited to 31 March 2016 (GBP) Fixed Assets Investments 2,375,370 Current Assets Sundry Debtors 34,522 Uninvested cash 10,713 Current Liabilities Creditors: amounts due (51,777) -------------------------------- 2,368,828 Capital and Reserves Share Capital 23 Share Premium 1,890,142 Reserves 478,663 -------------------------------- 2,368,828 Shares in Issue 23,195,558 Net Asset Value per share 10.21 pence
Portfolio Details
Investments as at 31 Value % of Total Portfolio March 2016 ------------------------- ------------- -------------------- Magna Biopharma Income Fund GBP1,093,235 46.0% Regent Pacific Group GBP600,945 25.3% Summit Corporation GBP251,293 10.6% Other quoted holdings GBP96,082 4.0% Other unquoted holdings GBP333,815 14.1% Total GBP2,375,370 100.0% ------------------------- ------------- --------------------
For further information, please contact:
Port Erin Biopharma Northland Capital Peterhouse Capital Investments Limited Partners Limited Limited The Company Nomad and Joint Broker Broker Denham Eke Matthew Johnson/David Lucy Williams (+44) (0) 1624 639396 Hignell (+44) (0) 207 469 0936 (+44) (0) 203 861 6625
This information is provided by RNS
The company news service from the London Stock Exchange
END
NAVSELESAFMSESL
(END) Dow Jones Newswires
April 29, 2016 02:00 ET (06:00 GMT)
1 Year Port Erin Chart |
1 Month Port Erin Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions